Source: Francesoir


Italy has been talked about a lot since the start of the Covid crisis in 2020 with first of all a significant mortality at the beginning of the year, followed at the end of the year by the decision of the Council of State to give following the request of doctors on early treatment at home including hydroxychloroquine , request made among others, by Dr Mangiagalli and Stramezzi .

Following a final publication by the group of doctors specialists of infectious diseases Piedmont, Dr. Garavelli and colleagues demonstrate the efficiency of hydroxychloroquine ( HCQ ) in the reduction of mortality in hospitalized patients. This study was published in the “  Journal of Clinical Medicine  ”.

In this debriefing, speaking in French, Dr. Garavelli looks back on the situation in his country as well as their study, thus taking the measure between the early treatment at home defended victoriously at the Italian Council of State, hospitalizations or intensive care Dr. Garavelli tells us that “ the treatment based on hydroxychloroquine is effective in the early phase of the disease at home or upon arrival at the hospital 

It also describes the antiviral but also immunomodulatory properties of HCQ. When the patient goes into intensive care, it is too late for this treatment because it is no longer the virus that has its effect but other pathologies take over.

He also reviews the dosage of hydroxychloroquine used (400mg for 7 or 14 days) and also refers to the overdose used in the Recovery (2400mg of HCQ in the first 24 hours) and Solidarity studies. It also discusses the use and efficacy of ivermectin as an antiviral and immuno- modulator.

Related: How hydroxychloroquine works at the cellular level

Hydroxychloroquine approved in Italy: the full scientific report

Covid-19, Early Treatment, and America’s Frontline Doctors – The Dr Urso Interview

How much proof do you want? Hundreds of studies conclude – treat Covid-19 early with hydroxychloroquine!

Nebulized Hydroxychloroquine for COVID-19 Treatment: 80x Improvement in Breathing – Dr Vladimir Zelenko

Turkey studies the impact of hydroxychloroquine-azithromycin combination – No significant heart QT prolongation found

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »